Changes of Plasma hs-CRP Before and After Percutaneous Coronary Intervention and Its Relationship with Major Adverse Cardiovascular Events
CSTR:
Author:
Affiliation:

Department of Cardiology, the First Hospital of Peking University, Beijing 100034, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [17]
  • |
  • Related
  • | | |
  • Comments
    Abstract:

    Aim To evaluate the changes of plasma hs-CRP before and after percutaneous coronary intervention (PCI) and its relationship with major adverse cardiovascular events (MACE). Methods We selected 84 coronary heart disease (CHD) patients who were implanted DES. The hs-CRP level was measured before, 1 day and 30 days after the procedure. Telephone calls were made to make sure if the patients had suffered MACE including repeated angina pectoris, non-lethal myocardial infarction, in stent restenosis, repeated revascularization, cardiac death in the following year after the procedure. Results The hs-CRP decreased significantly at 30 days after PCI compared with baseline (2.80±4.66 mg/L vs. 7.52±17.90 mg/L, P<0.001) and the level at one day after procedure (2.80±4.66 mg/L vs. 10.00±24.81 mg/L, P<0.001). The level of hs-CRP in MACE group before PCI was significantly higher than that in MACE-free group (10.38±19.40 mg/L vs. 6.84±17.61 mg/L, P=0.018). Conclusions The hs-CRP level before PCI in CHD patients is associated with the incidence of MACE after the procedure. Patients with higher hs-CRP level before PCI got higher incidence of MACE. The inflammation of CHD patients subsides after PCI for 30 days. The change can be reflected by the changing concentration of hs-CRP.

    Reference
    [1] Mozaffarian D, Benjamin EJ, Go AS, et al.Heart disease and stroke statistics-2015 update:a report from the American Heart Association.Circulation, 5,1 (4):e29-322.
    [2] Niccoli G, Montone RA, Ferrante G, et al.The evolving role of inflammatory biomarkers in risk assessment after stent implantation.J Am Coll Cardiol, 0,6 (22):1 783-793.
    [3] Khouzam RN, Shaheen M, Aziz RK, et al.The important role of inflammatory biomarkers pre and post bare-metal and drug-eluting stent implantation.Can J Cardiol, 2,8 (6):700-705.
    [4] 甘祥海, 吕湛.NLRP3炎性小体在动脉粥样硬化发生发展中的作用.临床与病理杂志, 5,5 (3):462-468.
    [5] Niccoli G, Ferrante G, Mongiardo R, et al.Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.Cardiovasc Revasc Med, 7,8 (3):156-160.
    [6] Gaspardone A, Crea F, Versaci F, et al.Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina.Am J Cardiol, 8,2 (4):515-518.
    [7] Park DW, Lee CW, Yun SC, et al.Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation.Heart, 7,3 (9):1 087-092.
    [8] Niccoli G, Conte M, Cosentino N, et al.Baseline C-reactive protein serum levels and in-stent restenosis pattern after m-TOR inhibitors drug-eluting stent implantation.J Invasive Cardiol, 1,3 (1):16-20.
    [9] Dibra A, Ndrepepa G, Mehilli J, et al.Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.Am J Cardiol, 5,5 (10):1 238-240.
    [10] 邱林, 王智, 龚艳君, 等.冠心病患者冠状动脉药物洗脱支架植入前后高敏C反应蛋白和白细胞介素6的变化.中国动脉硬化杂志, 5,3 (1):59-63.
    [11] Li JJ.Inflammatory response, drug-eluting stent and restenosis.Chin Med J (Engl), 8,1 (6):566-572.
    [12] Ishikawa T, Hatakeyama K, Imamura T, et al.Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris.Am J Cardiol, 3,1 (3):287-292.
    [13] Haverkate F, Thompson SG, Pyke SD, et al.Production of C-reactive protein and risk of coronary events in stable and unstable angina.European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.Lancet, 7,9 (9050):462-466.
    [14] Inoue T, Kato T, Uchida T, et al.Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.J Am Coll Cardiol, 5,6 (2):239-245.
    [15] Tiong AY, Lowe HC, Freedman SB, et al.Lack of widespread inflammation after contemporary PCI.Int J Cardiol, 0,0 (1):82-87.
    [16] Gaspardone A, Versaci F, Tomai F, et al.C-reactive protein, clinical outcome, and restenosis rates after implantation of different drug-eluting stents.Am J Cardiol, 6,7 (9):1 311-316.
    [17] 韩治伟, 张丽芳, 郑金刚, 等.合并终末期肾病的冠心病特点及治疗现状.中国介入心脏病学杂志, 5,3 (11):638-642.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

WANG Zhi, QIU Lin, GONG Yan-Jun, YANG Fan, HONG Tao, HUO Yong. Changes of Plasma hs-CRP Before and After Percutaneous Coronary Intervention and Its Relationship with Major Adverse Cardiovascular Events[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(11):1104-1108.

Copy
Share
Article Metrics
  • Abstract:951
  • PDF: 1006
  • HTML: 0
  • Cited by: 0
History
  • Received:December 07,2015
  • Revised:March 07,2016
  • Online: December 02,2016
Article QR Code